STIMULAN(R) certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN(R) certified to resolve infection and reduce the need for secondary surgery STIMULAN(R) is ...
Please provide your email address to receive an email when new articles are posted on . Ninety-day risk of all-cause mortality was 11.2% and 9.9% for patients given a shorter or longer antibiotic ...
FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infections. EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader i ...
Please provide your email address to receive an email when new articles are posted on . Gram-negative bacteria comprise most of the CDC and WHO’s lists of critical and urgent antibiotic-resistant ...
Scientists at Duke University report they have developed a synthetic antibiotic that could be effective against drug-resistant superbugs and bacteria such as Salmonella, Pseudomonas, and E. coli.
Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...
Hospital uptake of newer antibiotics to treat multidrug-resistant gram-negative bacteria was low over a 5-year period, according to a retrospective cohort study. Fully 41.5% of episodes of ...
Animals house thousands of commensal bacterial species in their guts, which play an important role in maintaining the host’s health. 1 However, antibiotic treatment indiscriminately wipes out both ...